Published in TB and Outbreaks Week, June 29th, 1998
Researchers from Colorado State University; Merck Research Laboratories, West Point, Pennsylvania; the Pasteur Institute in Brussels, Belgium; and Texas A&M University looked at two potential vaccines for tuberculosis. One was based on a tuberculosis protein and the other was a piece of DNA from the bacterium. Both conferred protection against infection in guinea pigs.
The current vaccine, the bacillus Calmette-Guerin, or BCG, vaccine, has been...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.